New Recall Issued On Blood Pressure, Heart Failure Medications

Leslie Hanson
January 5, 2019

A blood pressure medication is being recalled after a possible carcinogen was found in the medication.

Additional blood pressure medications are being recalled because they may contain an impurity that could cause cancer, according to the U.S. Food and Drug Administration (FDA).

Aurobindo Pharma USA, voluntarily recalling two lots of Valsartan tablets, 26 lots of amlodipine and Valsartan combination tablets, and 52 lots of Valsartan and hydrochlorothiazide (HCTZ) combination tablets.

The NDEA is basically a substance that is present naturally in some of the foods as well as drinking water, industrial processes, and air pollution, among others.

A full list of the recalled products is posted on the FDA's website.

Patients taking the affected medication should continue taking the tablets as prescribed as the risk of stopping the medication without an alternative treatment is higher.

To date, there haven't been any reports of adverse reactions to the medications related to this recall. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. A doctor (R) examines a patient on September 25, 2012 in Godewaersvelde, northern France, during a medical check-up.

Other reports by Iphone Fresh

Discuss This Article